We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Survey of Buprenorphine Use Among "Out of Care" Population in France (P04933)(COMPLETED)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00756353
First Posted: September 22, 2008
Last Update Posted: April 15, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Indivior Inc.
  Purpose
This study was a survey of drug users who obtain buprenorphine from the black market and have used buprenorphine during the last month. Subjects were surveyed at various locations (streets, railway stations, etc.) with a few simple questions in order to describe the use of buprenorphine in this "out of care" population.

Condition
Drug Addiction

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: Out of Care Patient Survey

Resource links provided by NLM:


Further study details as provided by Indivior Inc.:

Primary Outcome Measures:
  • The objective of this survey is to describe quantitatively and qualitatively, the use of buprenorphine in the population who obtain buprenorphine only on black market or both on black market and in pharmacy. [ Time Frame: Not Applicable, cross-sectional description. ]

Secondary Outcome Measures:
  • This survey will provide data on patients in regards to their own experience in drug addiction. [ Time Frame: Not Applicable, cross-sectional description. ]

Enrollment: 600
Study Start Date: June 2006
Study Completion Date: December 2006
Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)
Groups/Cohorts
Wave 1
Wave 2

Detailed Description:
Participants were found from various places and using a "snow ball" technique.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The population in this survey includes drug users who are in the "out of care" population, found in various places (streets, railway stations) and via the "snow ball" technique.
Criteria

Inclusion Criteria:

  • Drug users who have obtained buprenorphine only on the black market or both on black market and in pharmacy.

Exclusion Criteria:

  • Patients who have obtained buprenorphine only from the pharmacy.
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Head, Clinical Trials Registry & Results Disclosure Group, Schering-Plough
ClinicalTrials.gov Identifier: NCT00756353     History of Changes
Other Study ID Numbers: P04933
First Submitted: September 19, 2008
First Posted: September 22, 2008
Last Update Posted: April 15, 2011
Last Verified: September 2008

Keywords provided by Indivior Inc.:
Heroin
Buprenorphine use

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Buprenorphine
Analgesics, Opioid
Narcotics
Central Nervous System Depressants
Physiological Effects of Drugs
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Narcotic Antagonists


To Top